Improvement of diabetic retinopathy with intravitreal Ranibizumab
Improvement of diabetic retinopathy with intravitreal Ranibizumab
复制标题
DOI：
10.1016/j.diabres.2013.01.006
复制
发表时间：
2013-04-01
影响因子：
5.1
通讯作者：
Reznicek, Lukas
中科院分区：
文献类型：
--
作者：
Kernt, Marcus;Cserhati, Sarah;Reznicek, Lukas
这项研究表明，除了视力显著改善和中心累及糖尿病黄斑水肿患者的中央视网膜厚度降低外，雷珠单抗玻璃体内抗VEGF治疗还可能导致糖尿病视网膜病变的显著稳定甚至改善。(C)2013爱思唯尔爱尔兰有限公司版权所有。
This study indicates that in addition to the significant improvement in visual acuity and reduction of central retinal thickness in patients with center-involving diabetic macular edema, intravitreal anti-VEGF treatment with Ranibizumab may also lead to a significant stabilization or even improvement of diabetic retinopathy. (C) 2013 Elsevier Ireland Ltd. All rights reserved.